CANbridge Pharmaceuticals Inc. (HK:1228) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
CANbridge Pharmaceuticals Inc. has announced the resignation of Dr. Kan Chen as a non-executive Director and member of the audit committee, effective September 2, 2024. Dr. Chen’s departure is due to a desire to focus on personal commitments, with no reported disagreements or contentious issues related to his resignation. In his stead, Dr. Richard James Gregory will join the audit committee, as the company expresses gratitude to Dr. Chen for his service.
For further insights into HK:1228 stock, check out TipRanks’ Stock Analysis page.